V2X, Inc. (VVX): what the price requires

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/VVX

Headline

Field	Value
Ticker	VVX
Company	V2X, Inc.
Current price	$74.38/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	whole-company
Operating margin needed	1.9%
Operating margin today	4.1%
Margin compression implied	-2.2pp
Implied growth	0.9%
Multiple paid	18x operating income

The operating-margin requirement is derived from the framework's value band at year 8, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 7.5% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~7.4pp.

Reconcile: at the x-ray's 9.3% required return this reads ~13.1%/yr; the models below use their own rates.

How unusual the bet is: within-range

Reference	Value
vs own history	-0.57σ
cohort percentile (of 225 peers)	34
implied end-window share	0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	2.63x	5	expensive
Earnings	5.94x	5	expensive
Relative	1.48x	5	expensive
Growth	0.84x	3	justifies

Families that justify the price: Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.6%); the inversion above states its own rate.

Per-Model Detail (n=18)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	$107.84	0.69x	yes	FCF base $0.1B, growth 9% (input: historical growth), terminal g 4.0%, WACC 7.6%, 6yr projection
DCF Exit Multiple	Growth	$88.62	0.84x	yes	Exit EV/EBITDA: 14.4x / 16.4x / 18.4x (bear / base = today's held flat / bull), 6yr
Relative Valuation	Relative	$50.26	1.48x	yes	P/E 18x (static sector reference · 2026-04), scenarios: 14.9x / 18.0x / 21.1x (bear / base = reference held flat / bull), EV/EBITDA 12x
Simple DDM	Growth	—	—	no	—
Two-Stage DDM	Growth	—	—	no	—
Simple Excess Return	Asset	$30.43	2.44x	yes	BV/sh $35.02, ROE (TTM) 8.0%, ke 9.3%
Two-Stage Excess Return	Asset	$28.33	2.63x	yes	5yr excess ROE then converge to ke=9.3%
Discounted Future Market Cap	Growth	$61.69	1.21x	yes	Rev $4.7B, growth 9% (input: historical growth; tapered), Terminal P/S: 0.4x / 0.5x / 0.6x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair Value	Relative	$33.60	2.21x	yes	EPS $2.80, growth 2% (input: historical EPS growth), PEG=16.75 (Overvalued)
Margin Trajectory	Growth	—	—	no	—
Earnings Power Value	Earnings	$7.41	10.04x	yes	Normalized EBIT (5y avg op income, one-time charges added back) $0.12B × (1−20%) / WACC 7.6% → EPV (no growth)
Residual Income	Asset	$28.00	2.66x	yes	BV $35.02 + 5yr PV of (ROE (TTM) 8.0% − Kₑ 9.3%) × BV; BV grows 5.2%/yr
Graham Number	Asset	$46.97	1.58x	yes	√(22.5 × EPS $2.80 × BVPS $35.02) — Graham's conservative floor
EV/EBITDA Relative	Relative	$45.08	1.65x	yes	EBITDA $0.21B × sector EV/EBITDA 12.0x
FCF Yield	Earnings	$12.53	5.94x	yes	FCF $136.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF Yield	Earnings	$8.04	9.25x	yes	SBC-adj FCF $0.12B (FCF $0.14B − SBC $0.01B) capitalized at Kₑ
Ben Graham Formula	Earnings	$90.35	0.82x	yes	EPS $2.80 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/B	Asset	$7.50	9.92x	yes	BV $35.02 × (ROIC 1.6% / WACC 7.6%)
P/Sales Sector	Relative	$374.32	0.20x	yes	Revenue $4.72B × sector P/S 2.5x
PEG Fair Value	Relative	$105.00	0.71x	yes	EPS $2.80 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings Yield	Earnings	$30.27	2.46x	yes	EPS $2.80 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Net debt	$1.1b
Net debt / NOPAT (after-tax)	7.15x
Net debt / operating income (pre-tax)	5.75x
Share count CAGR (dilution)	27.5%
Burning cash	no

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

• V2X provides operations, logistics, and engineering services to the US government, mostly defense, with a long contracted revenue base; year-end backlog was "$11.1 billion, which included $2.3 billion in funded backlog," and recent awards have pushed it to a record.
• The defining risk is single-customer dependence: nearly all revenue comes from the US government, which the 10-K notes "may cancel any contract at any time through a termination for convenience."
• What to watch is backlog conversion and deleveraging: management raised full-year 2026 guidance and targets a net leverage ratio below 2.0 times by year-end, down from about 2.5 times.

Bull Case

Read the balance sheet first, because for a government-services contractor formed by a large merger, leverage is the variable that decides whether the equity compounds or just treads water, and V2X is deleveraging on schedule. The company carried merger debt into this business, but it generates real cash from operations and is steadily paying that debt down, with net leverage improving toward the 2.5-times range and management guiding to below 2.0 times by the end of 2026. A services contractor that converts its contracts into cash and uses that cash to delever is doing exactly what turns an over-levered post-merger story into a cleaner equity over time.

The revenue base underneath is unusually visible. V2X works on long-term government contracts, and the 10-K reports total backlog of "$11.1 billion, which included $2.3 billion in funded backlog," revenue the company expects to recognize as work is performed. Recent contract awards have pushed the backlog to a record, with management noting that the large majority of backlog revenue is already under contract, giving multi-year visibility that few industrial businesses can match. The work itself is essential and sticky: operating and sustaining military bases, aircraft, and logistics is the kind of mission-critical service that customers do not switch lightly, and incumbency on a contract is a real advantage at recompete.

The growth, while modest, is well-supported. The price implies only about 4.5% operating growth for five years, a pace within what V2X has recently delivered and a low bar relative to the demanding bets in this sector. Revenue rose sharply as several programs ramped, the 10-K noting US program revenue increased "$220.6 million" in the period, and the company is diversifying its customer base beyond the traditional Army, Navy, and Air Force accounts. A contractor with record backlog, improving leverage, and a modest implied growth bar is priced for steady execution, not for a miracle, and the recent awards suggest the pipeline supports it.

Bear Case

The structural truth a holder has to face is that V2X has essentially one customer, and that customer holds all the leverage in the relationship. Nearly all of the revenue comes from the US government, and government contracting is not a normal commercial relationship. The 10-K states plainly that the customer "may cancel any contract at any time through a termination for convenience," and that backlog, the bull case's favorite number, is not guaranteed revenue: the company "may not realize the full amount of our backlog as revenue, particularly unfunded backlog and future services where the customer has an option to decline." Of the headline backlog, only a fraction is actually funded. The rest depends on appropriations, options being exercised, and contracts surviving recompete. A single lost recompete or a budget squeeze can remove a large block of expected revenue at once.

The backlog itself has shown it can shrink. The 10-K discloses that total backlog "decreased by $1.4 billion" over the year before recent awards reversed it, a reminder that the contracted base is not a one-way ratchet. Government-services margins are structurally thin, in the low single digits at the operating line, because much of the work is cost-plus or competitively bid, so there is little cushion if a program runs over cost or a recompete forces a price concession. This is a business where revenue can be large and visible while the profit on it stays slim.

The leverage compounds the customer concentration. Net debt above $1 billion at roughly five times operating income on the trailing figures means the deleveraging story has to keep working for the equity to do well, and the merger that created V2X also inflated the share count substantially, so existing holders own a smaller slice. The static value methods are sobering: the earnings-power method, capitalizing thin normalized profit, lands near $7, and book value per share is about $35, both far below the price near $86 (June 28, 2026). Only the growth-projecting methods reach the price, which means the valuation rests entirely on the backlog converting and the margins holding. If a major recompete is lost or government budgets tighten, the methods that do not assume smooth execution are a long way down.

Valuation

The price is making a steady-execution bet, and by this sector's standards it is a reasonable one. At about $86 the market pays roughly 20 times company-wide operating income, which inverts to operating growth of about 4.5% a year for five years. That pace is within what V2X has recently delivered, and the implied bar is modest, so the question is less whether the company can grow than whether it can convert its backlog and hold its thin margins while paying down debt.

The methods we use to triangulate share a familiar shape for a leveraged services roll-up. The static value lenses land well below the price: the earnings-power method, which capitalizes normalized operating profit with no growth, sits near $7, and the asset-value methods, anchored on book value per share around $35, land in the high $20s to low $30s. The peer-multiple lens reaches the low-to-mid $60s. Only the forward-growth methods reach the price, with the perpetual-growth and exit-multiple cash-flow methods landing near it. When only the growth frames reach the price and the static frames say richly valued, the premium pays for durable contracted compounding the static methods cannot frame, which for a business with record backlog and multi-year visibility is at least coherent. The peer cohort here, engineering and consulting services names, is an adjacency rather than a pure defense-services comp, so the cleaner read is V2X against its own backlog conversion and leverage trajectory.

Solvency is the swing factor and the bull case's strongest claim. Net debt above $1 billion is meaningful, but it is falling, and the company generates the cash to keep cutting it, targeting a net leverage ratio below 2.0 times by the end of 2026. The thin margins mean the cash conversion, not the reported earnings, is the number that matters, and it is improving. The downside is bounded by the contracted backlog and the essential nature of the work; the risk is that the customer concentration and the leverage leave little room if a major recompete goes the wrong way.

Catalysts

V2X's first quarter of 2026 showed both the growth and the deleveraging working. Revenue rose about 23% year over year to roughly $1.25 billion, with GAAP net income of about $18.9 million and adjusted net income of about $48.1 million, up 53%. The standout was the award activity: the company booked roughly 50 awards totaling about $4.1 billion, including a $3.3 billion T-6 contract, driving total backlog to a record near $13.8 billion, with management noting about 94% of backlog revenue is under contract.

Guidance moved up across the board. Management raised full-year 2026 guidance to revenue of $4.825 to $4.975 billion, adjusted EBITDA of $345 to $360 million, and adjusted net cash from operations of $160 to $180 million. On the balance sheet, net debt improved to about $895 million, a roughly $77 million reduction year over year, putting net leverage near 2.5 times with a target below 2.0 times by year-end 2026. The company also continued to diversify, with about 21% of revenue from customers outside the Army, Navy, and Air Force, up from 13% a year earlier. The watch items are the pace of backlog conversion, the next round of recompetes, and whether the leverage target is hit on schedule.

Peer Cohorts (Per Segment, With Filing Citations)

V2X (single reportable segment - government services) (reported)

• BAH (BOOZ ALLEN HAMILTON HOLDING CORPORATION)
• (no filing in the citation store)
• LDOS (Leidos Holdings, Inc.)
• (no filing in the citation store)
• SAIC (Science Applications International Corporation)
• (no filing in the citation store)
• KBR (KBR, Inc.)
• (no filing in the citation store)
• J (JACOBS SOLUTIONS INC.)
• (no filing in the citation store)
• ACM (AECOM)
• (no filing in the citation store)
• VSEC (VSE CORPORATION)
• (no filing in the citation store)

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release, 2026 · Q1 2026 guidance, 2026 · Q1 2026 earnings call, 2026